Britain's government watchdog says there is still a "significant amount" of work to do to make sure the country has an adequate supply of licensed drugs in case of a no-deal Brexit.
In a report issued Friday, Britain's National Audit Office said additional shipping capacity chartered by the UK for sending goods across the English Channel might not be operational until the end of November one month after the October 31 deadline for Britain to leave the European Union.
Of the more than 12,300 medicines licensed in the UK, about 7,000 arrive from or via the EU, mostly across the Channel.
Meg Hillier, who chairs a committee overseeing the audit office, called the findings "deeply concerning."
"But the same approach has not been adopted this time."
Dr Richard Torbett of the Association of the British Pharmaceutical Industry said that while companies have been working to prepare for Brexit, "some things are outside of their control."